39 results
POS AM
SYRE
Spyre Therapeutics Inc.
26 Mar 24
Prospectus update (post-effective amendment)
6:30pm
, the U.S. domestic bribery statute contained in 18 U.S.C. § 201, the U.S. Travel Act, the USA PATRIOT Act, and other state and national anti-bribery … products and marketing of such products, both before and after grant of MA, statutory health insurance, bribery and anti-corruption or other applicable
424B3
SYRE
Spyre Therapeutics Inc.
18 Mar 24
Prospectus supplement
4:06pm
of the Securities or the Conversion Shares, including by any form of general solicitation or general advertising.
(ee) Anti-Corruption and Anti-Bribery … provision of the U.S. Foreign Corrupt Practices Act of 1977, as amended (the “FCPA”), the UK Bribery Act 2010, or any other applicable anti-bribery
8-K
EX-10.1
SYRE
Spyre Therapeutics Inc.
18 Mar 24
Spyre Therapeutics Announces $180 Million Private Placement
8:31am
, including by any form of general solicitation or general advertising.
(ee) Anti-Corruption and Anti-Bribery Laws. Neither the Company nor any of its … Practices Act of 1977, as amended (the “FCPA”), the UK Bribery Act 2010, or any other applicable anti-bribery or anti-corruption Law; or (iv) made
POS AM
SYRE
Spyre Therapeutics Inc.
14 Mar 24
Prospectus update (post-effective amendment)
4:12pm
Department’s Office of Foreign Assets Controls, the U.S. Foreign Corrupt Practices Act of 1977, as amended, the U.S. domestic bribery statute … contained in 18 U.S.C. § 201, the U.S. Travel Act, the USA PATRIOT Act, and other state and national anti-bribery and anti-money laundering laws
POS AM
4dvgqg7o062ghx
5 Mar 24
Prospectus update (post-effective amendment)
5:15pm
424B3
xb4w96is58l 7do23hy
8 Dec 23
Prospectus supplement
4:06pm
8-K
EX-10.1
4458dsc ta
8 Dec 23
Spyre Therapeutics Announces $180 Million Private Placement
8:45am